CND Life Sciences (CND), an Arizona-based medical technology company involved in the development of cutaneous neurodiagnostic tests and associated biomarker services, announced on Wednesday that it has named Hernan Lopez as its new chief operating officer, Kathryn Van Wie as vice president of Strategy & Business Development, Annemarie Benton as vice president of Market Access and Bryan May as vice president of Information Technology.

Lopez has around 20 years of experience in medical device and life sciences companies. He has served as the executive vice president of Operations at GT Medical Technology. He has handled explosive growth venture-backed company operations with successful exits, supported post-merger integrations, and worked in various operations roles in contract manufacturing organisations and multinational medical device companies like Boston Scientific.

Van Wie, an attorney, has served for a decade at Vertex Pharmaceuticals as Corporate Counsel and subsequently in US Marketing and as chief of staff in Commercial Strategy and Operations.

Benton has over 17 years of experience in the life sciences and advanced diagnostic laboratory industries. She has served as a molecular scientist and as head of Managed Care at Bionano and led the payer relations and handled care department at Caris Life Sciences.

May has more than 25 years of experience across diverse industries including healthcare, distribution, supply chain, and contract manufacturing. He has served at Atara Biotherapeutics where he supported infrastructure and cloud services across three sites. He has also served as the senior director of Infrastructure Services and Cloud Engineering at McKesson for 15 years.